Moving Cell And Gene Therapies Into Chronic Conditions Depends On Durability, Safety
Technologies, Trials Designed For Long-Term Efficacy, Safety
Safety and durability data are a key piece of the puzzle for cell and gene therapies in chronic diseases 
